{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:10:13Z","timestamp":1761235813995},"reference-count":73,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Japanese encephalitis is a flaviviral disease that is endemic to the South, Southeast Asia, and Asia Oceania regions. Given that about 60% of the world\u2019s population (about 7.4 billion) resides in this region (about 4.4 billion), this disease poses a significant threat to global health. Active vaccination campaigns conducted in endemic countries have led to a decrease in the number of reported cases over the years. In this article, we strive to briefly highlight recent advances in understanding the role of microRNAs in disease pathology, focus on providing brief summaries of recent clinical trials in the field of Japanese encephalitis therapeutics, and review the current prophylactic strategies.<\/ns4:p>","DOI":"10.12688\/f1000research.9561.1","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T15:45:13Z","timestamp":1489419913000},"page":"259","update-policy":"http:\/\/dx.doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Recent advances in Japanese encephalitis"],"prefix":"10.12688","volume":"6","author":[{"given":"Anirban","family":"Basu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kallol","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"ref-1","first-page":"326-334","article-title":"Japanese encephalitis: pathogenesis, prophylactics and therapeutics.","volume":"98","author":"K Dutta","year":"2010","journal-title":"Curr Sci."},{"key":"ref-2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10832","article-title":"Vector-free transmission and persistence of Japanese encephalitis virus in pigs.","volume":"7","author":"M Ricklin","year":"2016","journal-title":"Nat Commun."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"766-74","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review.","volume":"89","author":"G Campbell","year":"2011","journal-title":"Bull World Health Organ."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1624-36","DOI":"10.1111\/j.1471-4159.2008.05511.x","article-title":"Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation.","volume":"106","author":"S Das","year":"2008","journal-title":"J Neurochem."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"101-39","DOI":"10.1016\/B978-0-12-415795-8.00002-7","article-title":"The role of microRNAs in viral infection.","volume":"102","author":"A Roberts","year":"2011","journal-title":"Prog Mol Biol Transl Sci."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"53-61","DOI":"10.1016\/j.virusres.2015.01.026","article-title":"Functional non-coding RNAs derived from the flavivirus 3' untranslated region.","volume":"206","author":"B Clarke","year":"2015","journal-title":"Virus Res."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12985-016-0541-3","article-title":"A glance at subgenomic flavivirus RNAs and microRNAs in flavivirus infections.","volume":"13","author":"L Bavia","year":"2016","journal-title":"Virol J."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"1464-72","DOI":"10.1128\/JVI.02091-10","article-title":"Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.","volume":"85","author":"B Heiss","year":"2011","journal-title":"J Virol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"5915-22","DOI":"10.1016\/j.vaccine.2011.09.102","article-title":"Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome.","volume":"31","author":"L Yen","year":"2013","journal-title":"Vaccine."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"143-54","DOI":"10.1111\/jnc.12609","article-title":"MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3.","volume":"129","author":"M Thounaojam","year":"2014","journal-title":"J Neurochem."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"4798-810","DOI":"10.1128\/JVI.02979-13","article-title":"MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1.","volume":"88","author":"M Thounaojam","year":"2014","journal-title":"J Virol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1742-2094-11-97","article-title":"MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses.","volume":"11","author":"S Pareek","year":"2014","journal-title":"J Neuroinflammation."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-015-0249-0","article-title":"miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells.","volume":"12","author":"N Sharma","year":"2015","journal-title":"J Neuroinflammation."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"2251-62","DOI":"10.4049\/jimmunol.1500370","article-title":"MicroRNA-15b Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF125.","volume":"195","author":"B Zhu","year":"2015","journal-title":"J Immunol."},{"key":"ref-15","doi-asserted-by":"publisher","DOI":"10.1038\/srep22581","article-title":"Transcriptional regulation of miR-15b by c-Rel and CREB in Japanese encephalitis virus infection.","volume":"6","author":"B Zhu","year":"2016","journal-title":"Sci Rep."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"4780-95","DOI":"10.1128\/JVI.02586-15","article-title":"MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11.","volume":"90","author":"U Ashraf","year":"2016","journal-title":"J Virol."},{"key":"ref-17","doi-asserted-by":"publisher","DOI":"10.1038\/srep27685","article-title":"Japanese Encephalitis Virus exploits the microRNA-432 to regulate the expression of Suppressor of Cytokine Signaling (SOCS) 5.","volume":"6","author":"N Sharma","year":"2016","journal-title":"Sci Rep."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"2411-7","DOI":"10.2147\/NDT.S113236","article-title":"miR-370 mimic inhibits replication of Japanese encephalitis virus in glioblastoma cells.","volume":"12","author":"W Li","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"3722-34","DOI":"10.1128\/JVI.03242-15","article-title":"MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1.","volume":"90","author":"Z Chen","year":"2016","journal-title":"J Virol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12985-016-0562-y","article-title":"miR-124 attenuates Japanese encephalitis virus replication by targeting DNM2.","volume":"13","author":"S Yang","year":"2016","journal-title":"Virol J."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"342-7","DOI":"10.1016\/j.meegid.2015.03.037","article-title":"Integration analysis of miRNA and mRNA expression profiles in swine testis cells infected with Japanese encephalitis virus.","volume":"32","author":"Y Zhang","year":"2015","journal-title":"Infect Genet Evol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"148-62","DOI":"10.1128\/JVI.01399-12","article-title":"Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism.","volume":"87","author":"M Kalia","year":"2013","journal-title":"J Virol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"13407-22","DOI":"10.1128\/JVI.00903-12","article-title":"Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway.","volume":"86","author":"Y Zhu","year":"2012","journal-title":"J Virol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"76667-83","DOI":"10.18632\/oncotarget.12395","article-title":"MicroRNA-22 negatively regulates poly(I:C)-triggered type I interferon and inflammatory cytokine production via targeting mitochondrial antiviral signaling protein (MAVS).","volume":"7","author":"S Wan","year":"2016","journal-title":"Oncotarget."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"e21761","DOI":"10.1371\/journal.pone.0021761","article-title":"RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection.","volume":"6","author":"A Nazmi","year":"2011","journal-title":"PLoS One."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/srep00347","article-title":"STING mediates neuronal innate immune response following Japanese encephalitis virus infection.","volume":"2","author":"A Nazmi","year":"2012","journal-title":"Sci Rep."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12974-016-0748-7","article-title":"Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects.","volume":"13","author":"R Lindqvist","year":"2016","journal-title":"J Neuroinflammation."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"2204-19","DOI":"10.3390\/ijms16012204","article-title":"Identification and analysis of differentially-expressed microRNAs in Japanese encephalitis virus-infected PK-15 cells with deep sequencing.","volume":"16","author":"Y Cai","year":"2015","journal-title":"Int J Mol Sci."},{"key":"ref-29","doi-asserted-by":"publisher","DOI":"10.1038\/srep20263","article-title":"Dynamic changes in global microRNAome and transcriptome reveal complex miRNA-mRNA regulated host response to Japanese Encephalitis Virus in microglial cells.","volume":"6","author":"B Kumari","year":"2016","journal-title":"Sci Rep."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"249-57","DOI":"10.1016\/j.meegid.2016.01.028","article-title":"MicroRNA transcriptome profiling of mice brains infected with Japanese encephalitis virus by RNA sequencing.","volume":"39","author":"X Li","year":"2016","journal-title":"Infect Genet Evol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"1541-1551","DOI":"10.1007\/s12035-016-9764-y","article-title":"Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus.","volume":"54","author":"S Goswami","year":"2017","journal-title":"Mol Neurobiol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"309-335","DOI":"10.1007\/978-1-4939-1071-7_15","article-title":"Japanese Encephalitis: A Tale of Inflammation and Degeneration in the Central Nervous System.","author":"K Dutta","year":"2014","journal-title":"Neuroinflammation and Neurodegeneration."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"631-7","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus.","volume":"165","author":"C Hoke","year":"1992","journal-title":"J Infect Dis."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"821-6","DOI":"10.1016\/S0140-6736(03)12709-2","article-title":"Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.","volume":"361","author":"T Solomon","year":"2003","journal-title":"Lancet."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"400-6","DOI":"10.1086\/596309","article-title":"Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India.","volume":"48","author":"R Kumar","year":"2009","journal-title":"Clin Infect Dis."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1582-95","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.","volume":"105","author":"M Mishra","year":"2008","journal-title":"J Neurochem."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"464-70","DOI":"10.1016\/j.neuint.2009.01.022","article-title":"Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death.","volume":"54","author":"M Mishra","year":"2009","journal-title":"Neurochem Int."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"717-23","DOI":"10.1016\/j.neuint.2009.07.006","article-title":"Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent.","volume":"55","author":"M Mishra","year":"2009","journal-title":"Neurochem Int."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"884-93","DOI":"10.1016\/j.imbio.2009.12.003","article-title":"Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection.","volume":"215","author":"K Dutta","year":"2010","journal-title":"Immunobiology."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"553-65","DOI":"10.1007\/s11481-010-9233-8","article-title":"Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis.","volume":"5","author":"K Dutta","year":"2010","journal-title":"J Neuroimmune Pharmacol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"e17225","DOI":"10.1371\/journal.pone.0017225","article-title":"Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis.","volume":"6","author":"S Das","year":"2011","journal-title":"PLoS One."},{"key":"ref-42","first-page":"467-70","article-title":"Use of minocycline in viral infections.","volume":"133","author":"K Dutta","year":"2011","journal-title":"Indian J Med Res."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12879-016-1385-6","article-title":"Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial.","volume":"16","author":"R Kumar","year":"2016","journal-title":"BMC Infect Dis."},{"key":"ref-44","doi-asserted-by":"crossref","first-page":"371-377","DOI":"10.17511\/ijpr.2016.i05.18","article-title":"Minocycline trial in japanese encephalitis: a double blind, randomized placebo study.","volume":"3","author":"A Singh","year":"2016","journal-title":"Int J Pediatr Res."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"480-4","DOI":"10.1016\/S0140-6736(75)92830-5","article-title":"Assessment of outcome after severe brain damage.","volume":"1","author":"B Jennett","year":"1975","journal-title":"Lancet."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"584-92","DOI":"10.2471\/BLT.09.071357","article-title":"Disability after encephalitis: development and validation of a new outcome score.","volume":"88","author":"P Lewthwaite","year":"2010","journal-title":"Bull World Health Organ."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"e0122608","DOI":"10.1371\/journal.pone.0122608","article-title":"A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.","volume":"10","author":"A Rayamajhi","year":"2015","journal-title":"PLoS One."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"e1311","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.","volume":"5","author":"K Anderson","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-49","first-page":"237-44","article-title":"A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.","volume":"73","author":"A Gajanana","year":"1995","journal-title":"Bull World Health Organ."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"1620-1","DOI":"10.1086\/509644","article-title":"Role of intravenous immunoglobulin administration in Japanese encephalitis.","volume":"43","author":"P Caramello","year":"2006","journal-title":"Clin Infect Dis."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"5-12","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.","volume":"188","author":"D Ben-Nathan","year":"2003","journal-title":"J Infect Dis."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"43-6","DOI":"10.7812\/TPP\/09-028","article-title":"Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.","volume":"13","author":"M Walid","year":"2009","journal-title":"Perm J."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"S13-21","DOI":"10.1212\/WNL.59.12_suppl_6.S13","article-title":"Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.","volume":"59","author":"M Dalakas","year":"2002","journal-title":"Neurology."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"753-64","DOI":"10.1189\/jlb.0412214","article-title":"Regulation of inflammation by interleukin-4: a review of \"alternatives\".","volume":"92","author":"I Luzina","year":"2012","journal-title":"J Leukoc Biol."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"1618-26","DOI":"10.1086\/423328","article-title":"Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.","volume":"190","author":"P Winter","year":"2004","journal-title":"J Infect Dis."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"119-30","DOI":"10.1016\/j.virol.2005.09.024","article-title":"The interferon response circuit: induction and suppression by pathogenic viruses.","volume":"344","author":"O Haller","year":"2006","journal-title":"Virology."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"8035-43","DOI":"10.4049\/jimmunol.0902728","article-title":"Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.","volume":"183","author":"R Lin","year":"2009","journal-title":"J Immunol."},{"key":"ref-58","doi-asserted-by":"publisher","DOI":"10.1038\/srep33698","article-title":"TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A.","volume":"6","author":"W Fan","year":"2016","journal-title":"Sci Rep."},{"key":"ref-59","first-page":"255-62","article-title":"The CRISPR\/Cas9 genome editing methodology as a weapon against human viruses.","volume":"19","author":"M White","year":"2015","journal-title":"Discov Med."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"5279-83","DOI":"10.1016\/j.vaccine.2016.09.005","article-title":"Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.","volume":"34","author":"P Janewongwirot","year":"2016","journal-title":"Vaccine."},{"key":"ref-61","article-title":"Background paper on Japanese encephalitis vaccines","year":"2014"},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"846-853","DOI":"10.1111\/1348-0421.12458","article-title":"Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.","volume":"60","author":"E Lee","year":"2016","journal-title":"Microbiol Immunol."},{"key":"ref-63","first-page":"150-5","article-title":"[Generation of Japanese Encephalitis Virus-like Particle Vaccine and Preliminary Evaluation of Its Protective Efficiency].","volume":"32","author":"Y Zhang","year":"2016","journal-title":"Bing Du Xue Bao."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"2656-63","DOI":"10.4161\/hv.29743","article-title":"A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.","volume":"10","author":"D Kim","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"1371-84","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV\u00ae: a Yellow fever virus-based novel Japanese encephalitis vaccine.","volume":"9","author":"M Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"715-25","DOI":"10.1093\/infdis\/jiv023","article-title":"A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains.","volume":"212","author":"A Singh","year":"2015","journal-title":"J Infect Dis."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"166-8","DOI":"10.1093\/inthealth\/iht015","article-title":"Japanese encephalitis in India: risk of an epidemic in the National Capital Region.","volume":"5","author":"D Adhya","year":"2013","journal-title":"Int Health."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"45-9","DOI":"10.1016\/j.jcv.2011.06.001","article-title":"A comparison of clinical features of Japanese encephalitis virus infection in the adult and pediatric age group with Acute Encephalitis Syndrome.","volume":"52","author":"J Borah","year":"2011","journal-title":"J Clin Virol."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"e3030","DOI":"10.1371\/journal.pntd.0003030","article-title":"The incidence of Japanese encephalitis in Taiwan--a population-based study.","volume":"8","author":"L Hsu","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"319-21","DOI":"10.3201\/eid1702.100815","article-title":"Introduction of Japanese encephalitis virus genotype I, India.","volume":"17","author":"P Fulmali","year":"2011","journal-title":"Emerg Infect Dis."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"9847-53","DOI":"10.1128\/JVI.00825-11","article-title":"Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia.","volume":"85","author":"X Pan","year":"2011","journal-title":"J Virol."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"2127-30","DOI":"10.1016\/j.vaccine.2010.12.108","article-title":"Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.","volume":"29","author":"X Liu","year":"2011","journal-title":"Vaccine."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"e0004686","DOI":"10.1371\/journal.pntd.0004686","article-title":"Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.","volume":"10","author":"L Cao","year":"2016","journal-title":"PLoS Negl Trop Dis."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/6-259\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-259\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-259\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T20:14:38Z","timestamp":1601756078000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/6-259\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":73,"URL":"https:\/\/doi.org\/10.12688\/f1000research.9561.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.10298.r20519","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.10298.r20516","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.10298.r20518","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.10298.r20517","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/6-259\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.10298.r20519, Alan Barrett, Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch at Galveston, Galveston, USA, 13 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-259\/v1#referee-response-20519","order":0,"name":"referee-response-20519","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.10298.r20518, Arup Banerjee, Vaccine and Infectious Disease Research Center (VIDRC), Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad, India, 13 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-259\/v1#referee-response-20518","order":1,"name":"referee-response-20518","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.10298.r20517, Sabarish Vellatheri Indran, Institute of Life Sciences, Bhubaneswar, Odisha, India, 13 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-259\/v1#referee-response-20517","order":2,"name":"referee-response-20517","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.10298.r20516, Shengbo Cao, State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China, 13 Mar 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-259\/v1#referee-response-20516","order":3,"name":"referee-response-20516","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"AB is a recipient of a Tata Innovation Fellowship (BT\/HRD\/35\/01\/02\/2014) from the Department of Biotechnology, Government of India.","order":4,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}